Antigens, Differentiation, Myelomonocytic
Research News and Information

Sunday, March 21, 2010

Diagnostic value of CD163 in cutaneous spindle cell lesions.

22 Nov 2009 BACKGROUND: The histologic diagnosis of atypical fibroxanthoma (AFX) can sometimes be challenging. No specific marker exists to confirm the diagnosis other than excluding other entities. CD163 has been shown to have great specificity for tumors of ... Read more...

Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time.

13 Oct 2009 Expression of the macrophage antigen CD163 in breast cancer cells is recently shown to be related to early distant recurrence and shortened survival. In this study, 163 patients with rectal cancer, included in the Swedish rectal cancer trial and ... Read more...

Chromosome 8 pentasomy with partial tandem duplication of 11q23 in a case of de novo acute myeloid leukemia.

29 Sep 2009 Polysomy 8 is a rare abnormality, one that has been reported as associated with secondary evolution, monocytic differentiation, or poor prognosis in myeloid neoplasm. In contrast to tetrasomy 8, which is most commonly observed, pentasomy 8 is a ... Read more...

Latest indexed articles for 'Antigens, Differentiation, Myelomonocytic'

These are the very latest articles for this heading:

• Diagnostic value of CD163 in cutaneous spindle cell lesions. 22 Nov 2009
• Expression of the macrophage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. 13 Oct 2009
• Chromosome 8 pentasomy with partial tandem duplication of 11q23 in a case of de novo acute myeloid leukemia. 29 Sep 2009
• Duplication of isodicentric chromosome 21, idic(21)(p11.2), leading to pentasomy 21q in acute myeloid leukemia with multilineage dysplasia. 29 Sep 2009
• Anti-Siglec-F antibody reduces allergen-induced eosinophilic inflammation and airway remodeling. 23 Sep 2009
• A dual role for HSP90 and HSP70 in the inflammatory myopathies: from muscle fiber protection to active invasion by macrophages. 30 Aug 2009
• Distribution of the NF-kappaB complex in the inflammatory exudates characterizing the idiopathic inflammatory myopathies. 30 Aug 2009
• Phenotype for activated tissue macrophages in histiocytic necrotizing lymphadenitis. 30 Aug 2009
• Parathyroid hormone-related protein protects against mammary tumor emergence and is associated with monocyte infiltration in ductal carcinoma in situ. 30 Aug 2009
• The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. 24 Aug 2009
• Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis. 24 Aug 2009
• [Molecular-targeted drugs. 1) Indications and the application of molecular-targeted drugs in hematological diseases] 8 Aug 2009
• Synovial tissue sublining CD68 expression is a biomarker of therapeutic response in rheumatoid arthritis clinical trials: consistency across centers. 30 Jul 2009
• Extensive astrocyte infection is prominent in human immunodeficiency virus-associated dementia. 30 Jul 2009
• CD68 expression is markedly different in Crohn's disease and the colitis associated with chronic granulomatous disease. 30 Jul 2009
• Prognostic impact of CD68 and kallikrein 6 in human glioma. 30 Jul 2009
• Lymph node melanosis in a patient with metastatic melanoma of unknown primary. 30 Jul 2009
• The expression of CD68 in human umbilical cord mesenchymal stem cells: new evidences of presence in non-myeloid cell types. 30 Jul 2009
• Sinus histiocytosis with massive lymphadenopathy: a case report with pleural effusion and cervical lymphadenopathy. 28 Jul 2009
• IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. 28 Jul 2009

See a longer list of these articles.

Technical information about 'Antigens, Differentiation, Myelomonocytic'

Definition: Surface antigens expressed on myeloid cells of the granulocyte-monocyte-histiocyte series during differentiation. Analysis of their reactivity in normal and malignant myelomonocytic cells is useful in identifying and classifying human leukemias and lymphomas.

Registry Number: 0

Descriptor UI: D015214

Alternative terms: Antigens, Differentiation, Myelomonocytic; Myelomonocytic Differentiation Antigens; Antigens, Myelomonocytic, Differentiation; Differentiation Antigens, Myelomonocytic; Antigens, Myelomonocytic Differentiation;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; biosynthesis; blood; cerebrospinal fluid; classification; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacology; physiology; poisoning; radiation effects; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications;

Tree Number: D23.050.301.264.900; D23.101.100.900;

Online Note: use ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC to search LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, & LEU-M4 ANTIGENS 1989-94

History Note: 89; LEU ANTIGENS, MYELOMONOCYTIC, LEU-M1 ANTIGENS, LEU-M2 ANTIGENS, & LEU-M4 ANTIGENS were see ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC 1989-94

Technical Notes: DF: MM DIFFER ANTIGENS or ANTIGENS DIFFER MM